Herein, we studied the modifications of nasopharyngeal microbiota according to the clinical outcomes of COVID-19 patients, and highlighted specific nasopharyngeal microbiota biomarkers associated with

NIAID Data Ecosystem20

Nasopharyngeal microbiota and COVID-19

Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota cause secondary bacterial infection in COVID-19 patients and aggravate pneumonia.

NIAID Data Ecosystem30

Nasopharyngeal Microbiota in paediatric COVID-19

We explored the nasopharyngeal microbiota (NP) profile of children affected by COVID-19 by 16S rRNA targeted-metagenomics.

NIAID Data Ecosystem00

Nasopharyngeal microbiota and COVID--19